Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone

Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol

(2014) Human Mousavi Fatemi et al.   FERTILITY AND STERILITY

Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study

(2013) Nikolaos P. Polyzos et al.   FERTILITY AND STERILITY

Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis

(2013) Simone L. Broer et al.   FERTILITY AND STERILITY

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients

(2013) Joan-Carles Arce et al.   FERTILITY AND STERILITY

GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients

(2013) P. Humaidan et al.   HUMAN REPRODUCTION

Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG

(2013) A. Seyhan et al.   HUMAN REPRODUCTION

Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice

(2013) A. La Marca et al.   HUMAN REPRODUCTION UPDATE

Significantly Lower Pregnancy Rates in the Presence of Progesterone Elevation in Patients Treated with GnRH Antagonists and Gonadotrophins: A Systematic Review and Meta-Analysis

(2012) E. M. Kolibianakis et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach

(2012) Simone L. Broer et al.   HUMAN REPRODUCTION UPDATE

Anti-Müllerian Hormone Serum Values and Ovarian Reserve: Can It Predict a Decrease in Fertility after Ovarian Stimulation by ART Cycles?

(2012) Tito Silvio Patrelli et al.   PLoS One

Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors

(2012) Nikolaos P. Polyzos et al.   REPRODUCTIVE BIOMEDICINE ONLINE

The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

(2012) Theodora C van Tilborg et al.   BMC Womens Health

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles

(2011) Sesh Kamal Sunkara et al.   HUMAN REPRODUCTION

Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF

(2011) A. P. Yates et al.   HUMAN REPRODUCTION

Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment

(2011) A. N. Andersen et al.   HUMAN REPRODUCTION

Influence of female bodyweight on IVF outcome: a longitudinal multicentre cohort study of 487 infertile couples

(2011) A. Pinborg et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction

(2010) J. R. Lee et al.   HUMAN REPRODUCTION

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles

(2010) E. Bosch et al.   HUMAN REPRODUCTION

Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis

(2010) M. D. Sterrenburg et al.   HUMAN REPRODUCTION UPDATE